About   Help   FAQ
Mammalian Phenotype Ontology Annotations
Query Results - Summary
Symbol
Name
ID 		Nos3
nitric oxide synthase 3, endothelial cell
MGI:97362
233 phenotypes from 11 alleles in 19 genetic backgrounds
Export: Excel File
Allelic Composition
Genetic Background		 Annotated Term Reference
Nos3em1(IMPC)Mbp/Nos3em1(IMPC)Mbp
C57BL/6N-Nos3em1(IMPC)Mbp/Ucd 		abnormal epididymis morphology J:211773
abnormal kidney morphology J:211773
abnormal lymph node morphology J:211773
abnormal spleen morphology J:211773
decreased circulating phosphate level J:211773
decreased fasting circulating glucose level J:211773
decreased lymphocyte cell number J:211773
enlarged epididymis J:211773
enlarged lymph nodes J:211773
enlarged spleen J:211773
increased basophil cell number J:211773
increased blood urea nitrogen level J:211773
increased eosinophil cell number J:211773
increased heart weight J:211773
increased neutrophil cell number J:211773
small kidney J:211773
Nos3m1Btlr/Nos3m1Btlr
C57BL/6J-Nos3m1Btlr 		increased susceptibility to induced colitis J:225268
increased susceptibility to weight loss J:225268
Nos3M2Btlr/Nos3M2Btlr
C57BL/6J-Nos3M2Btlr 		increased susceptibility to induced colitis J:272392
Nos3tm1.1Taka/Nos3tm1.1Taka
involves: 129S4/SvJae * 129S6/SvEvTac * C57BL/6J 		no abnormal phenotype detected J:187860
Nos3tm1.2Taka/Nos3tm1.2Taka
involves: 129S4/SvJae * 129S6/SvEvTac * C57BL/6 * C57BL/6J * CBA 		abnormal renal glomerulus morphology J:187860
decreased heart rate J:187860
decreased kidney weight J:187860
increased circulating glucose level J:187860
increased circulating triglyceride level J:187860
increased mean systemic arterial blood pressure J:187860
increased systemic arterial systolic blood pressure J:187860
Nos3tm1Gdk/Nos3tm1Gdk
B6.129P2-Nos3tm1Gdk 		abnormal dopamine level J:64214
abnormal learning/memory/conditioning J:64214
abnormal serotonin level J:64214
abnormal spatial learning J:64214
decreased locomotor activity J:64214
enhanced long-term object recognition memory J:64214
increased anxiety-related response J:64214
Nos3tm1Gdk/Nos3tm1Gdk
involves: 129P2/OlaHsd * C57BL/6 		decreased heart rate J:46061
hypertension J:46061
increased vasoconstriction J:46061
Nos3tm1Plh/Nos3+
involves: 129S4/SvJae * C57BL/6 		abnormal pulmonary alveolus morphology J:83896
Nos3tm1Plh/Nos3tm1Plh
B6.129S4-Nos3tm1Plh 		abnormal cerebral blood flow rate J:107964
abnormal circulating glucose level J:155090
abnormal induced retina neovascularization J:106207
abnormal nervous system physiology J:107964
abnormal seizure response to inducing agent J:107964
abnormal systemic arterial blood pressure J:107964
abnormal vascular endothelial cell physiology J:155090
normal cardiovascular system phenotype J:106207
decreased adiponectin level J:155090
hypertension J:155090
increased circulating triglyceride level J:155090
increased white adipose tissue amount J:155090
Nos3tm1Plh/Nos3tm1Plh
involves: 129S4/SvJae 		abnormal blood flow velocity J:112419
abnormal ejaculation J:59686
abnormal heart right ventricle pressure J:57624, J:100308
abnormal leukocyte adhesion J:55936
abnormal neutrophil physiology J:55936
abnormal penile erection J:89704
abnormal pulmonary pressure J:57624
abnormal pulmonary vascular resistance J:112419
abnormal response/metabolism to endogenous compounds J:112419
abnormal systemic arterial blood pressure J:112419
abnormal systemic vascular resistance J:112419
abnormal vasodilation J:112419
decreased coronary flow rate J:60525
decreased heart rate J:60525, J:100308
decreased neurotransmitter release J:119052
decreased survivor rate J:100308
decreased vasodilation J:28778
enhanced leukocyte tethering or rolling J:55936
hypertension J:28778, J:60525
increased heart rate J:112419
increased mean systemic arterial blood pressure J:55936
increased susceptibility to neuronal excitotoxicity J:111644
increased systemic arterial blood pressure J:57624
increased vasoconstriction J:57624
insulin resistance J:62229
normal muscle phenotype J:56948
normal nervous system phenotype J:37956
premature death J:100308
pulmonary hypertension J:112419
Nos3tm1Plh/Nos3tm1Plh
involves: 129S4/SvJae * C57BL/6 		abnormal adipose tissue amount J:133437
abnormal associative learning J:101302
abnormal blood vessel physiology J:75645, J:108540
abnormal bone mineralization J:67336
abnormal dentate gyrus morphology J:101302
abnormal eye physiology J:66540
abnormal female meiosis J:89702
abnormal femur morphology J:67336
abnormal heart left ventricle morphology J:75645
abnormal hepatocyte morphology J:133437
abnormal induced retina neovascularization J:66540
abnormal liver morphology J:133437
abnormal liver physiology J:133437
abnormal long bone epiphyseal plate morphology J:67336
abnormal lung vasculature morphology J:83896
abnormal myocardial fiber physiology J:75645
abnormal neuron morphology J:101302
abnormal neuronal precursor proliferation J:101302
abnormal oocyte morphology J:89702
abnormal oogenesis J:89702
abnormal osteoblast physiology J:67336
abnormal ovary physiology J:89702
abnormal primary polar body morphology J:89702
abnormal pulmonary alveolus morphology J:83896
abnormal renal glomerulus morphology J:67336
abnormal superovulation J:58361
abnormal trabecular bone thickness J:67336
abnormal vascular wound healing J:119617, J:139343
decreased body weight J:83896
decreased bone mineral density J:67336
decreased cardiac muscle contractility J:75645
decreased circulating glucose level J:133437
decreased circulating insulin level J:133437
decreased litter size J:58361, J:89702
decreased physiological sensitivity to xenobiotic J:108540
decreased prostaglandin level J:108540
decreased superovulation rate J:89702
heart left ventricle hypertrophy J:75645
hepatic steatosis J:133437
normal homeostasis/metabolism phenotype J:133437
increased body weight J:133437
increased cardiac muscle contractility J:75645
increased circulating estradiol level J:89702
increased heart rate J:75645
increased susceptibility to bacterial infection J:105005
increased susceptibility to bacterial infection induced morbidity/mortality J:105005
increased systemic arterial systolic blood pressure J:75645, J:108540
maternal effect J:89702
reduced female fertility J:89702
short estrous cycle J:58361
short femur J:67336
small ovary J:89702
Nos3tm1Plh/Nos3tm1Plh
involves: 129S4/SvJae * C57BL/6J 		decreased ovulation rate J:89542
normal digestive/alimentary phenotype J:64225
increased circulating estradiol level J:89542
increased circulating progesterone level J:89542
prolonged diestrus J:89542
prolonged estrous cycle J:89542
Nos3tm1Unc/Nos3+
B6.129P2-Nos3tm1Unc/J 		postnatal lethality, incomplete penetrance J:103270
Nos3tm1Unc/Nos3+
involves: 129P2/OlaHsd * C57BL/6J 		increased vasodilation J:54772
Nos3tm1Unc/Nos3tm1Unc
B6.129P2-Nos3tm1Unc 		abnormal blood-brain barrier function J:150557
Nos3tm1Unc/Nos3tm1Unc
B6.129P2-Nos3tm1Unc/J 		abnormal angiogenesis J:98913
abnormal circulating protein level J:129477
abnormal glomerular capillary endothelium morphology J:148626
abnormal glomerular capillary thrombosis J:148626
abnormal heart morphology J:103270
abnormal interventricular septum membranous part morphology J:103270
abnormal kidney cortex morphology J:148626
abnormal kidney morphology J:117046
abnormal lung morphology J:98913
abnormal lung vasculature morphology J:98913
abnormal osteoblast physiology J:129477
abnormal osteoclast physiology J:129477
abnormal ovary morphology J:145649
abnormal pregnancy J:145649
abnormal proximal convoluted tubule morphology J:117046
abnormal redox activity J:98094
abnormal renal glomerulus morphology J:117046
abnormal renal tubule epithelium morphology J:148626
abnormal surfactant secretion J:103340
abnormal systemic arterial blood pressure J:148626
abnormal type II pneumocyte morphology J:98913
abnormal vascular branching morphogenesis J:98913
absent alveolar lamellar bodies J:98913
albuminuria J:148626
anovulation J:145649
bicuspid aortic valve J:103340
cardiac hypertrophy J:98094
cyanosis J:98913
decreased bone mineral density J:129477
decreased cardiac muscle contractility J:103270
decreased corpora lutea number J:145649
decreased fertilization frequency J:145649
decreased kidney cell proliferation J:148626
decreased ovulation rate J:145649
decreased vascular endothelial cell number J:148626
dilated renal glomerular capsule J:117046
dilated renal tubule J:148626
enlarged heart J:103270
expanded mesangial matrix J:148626
fetal growth retardation J:98913, J:140819
glomerulosclerosis J:117046, J:148626
impaired embryo implantation J:145649
increased blood urea nitrogen level J:148626
increased bone mineral density J:129477
increased circulating creatine kinase level J:148626
increased circulating osteocalcin level J:129477
increased compact bone thickness J:129477
increased fetal cardiomyocyte apoptosis J:103270
increased heart atrium size J:103270
increased heart left ventricle size J:103270
increased heart right ventricle size J:103270
increased heart ventricle muscle contractility J:98094
increased heart ventricle size J:103270
increased inflammatory response J:103018
increased kidney apoptosis J:148626
increased left ventricle systolic pressure J:98094
increased mesangial cell number J:148626
increased renal tubule apoptosis J:117046
increased susceptibility to induced aneurysm formation J:148626
kidney degeneration J:117046
kidney failure J:148626
kidney inflammation J:148626
lung hemorrhage J:98913
mesangiolysis J:148626
muscular ventricular septal defect J:103270
neonatal lethality, incomplete penetrance J:98913
ostium secundum atrial septal defect J:103270
postnatal lethality, incomplete penetrance J:103270
pulmonary alveolar edema J:103270
pulmonary vascular congestion J:103270
renal cast J:148626
renal glomerulus fibrosis J:148626
renal glomerulus hypertrophy J:148626
renal glomerulus lipidosis J:117046
renal hypoplasia J:117046
renal interstitial fibrosis J:117046, J:148626
renal tubular necrosis J:117046
respiratory distress J:98913
small ovary J:145649
thick pulmonary interalveolar septum J:98913
ventricular septal defect J:103270
Nos3tm1Unc/Nos3tm1Unc
BKS.129P2-Nos3tm1Unc 		albuminuria J:135864
increased systemic arterial systolic blood pressure J:135864
Nos3tm1Unc/Nos3tm1Unc
involves: 129P2/OlaHsd 		abnormal blood homeostasis J:103153
abnormal glucose homeostasis J:103153
abnormal heart morphology J:102136
abnormal interventricular septum morphology J:102136
abnormal systemic arterial blood pressure J:102136
cardiac hypertrophy J:102136
decreased body weight J:102136
decreased cardiac muscle contractility J:102136
decreased heart left ventricle posterior wall thickness J:102136
decreased vasodilation J:103153
dilated heart left ventricle J:102136
hyperlipidemia J:103153
hypertension J:102136, J:103153
increased circulating cholesterol level J:103153
increased circulating free fatty acids level J:103153
increased circulating insulin level J:103153
increased circulating triglyceride level J:103153
increased heart rate J:102136
increased heart weight J:102136
increased systemic arterial blood pressure J:102136
increased systemic arterial diastolic blood pressure J:102136
increased systemic arterial systolic blood pressure J:102136
insulin resistance J:103153
premature death J:102136
Nos3tm1Unc/Nos3tm1Unc
involves: 129P2/OlaHsd * C57BL/6 		abnormal cardiovascular system morphology J:101254
abnormal cardiovascular system physiology J:101254
abnormal heart right ventricle pressure J:101254
abnormal heart weight J:101254
abnormal pulmonary artery morphology J:101254
decreased body temperature J:113106
decreased body weight J:36559, J:101254
decreased heart rate J:36559
decreased susceptibility to induced morbidity/mortality J:113106
decreased vascular permeability J:113106
normal immune system phenotype J:36559
increased circulating renin level J:36559
increased mean systemic arterial blood pressure J:101254
increased systemic arterial blood pressure J:36559
Nos3tm1Unc/Nos3tm1Unc
involves: 129P2/OlaHsd * C57BL/6J 		abnormal vasodilation J:54772
decreased body weight J:36559
decreased heart rate J:36559, J:54772
normal homeostasis/metabolism phenotype J:64896
hypertension J:54772
increased circulating renin level J:36559
increased systemic arterial blood pressure J:36559
increased vasoconstriction J:54772
Nos3tm1Weo/Nos3tm1Weo
B6.129S7-Nos3tm1Weo 		abnormal fertility/fecundity J:89703
abnormal superovulation J:89703
decreased superovulation rate J:73964, J:89703
delayed female fertility J:89703
early reproductive senescence J:89703
impaired fertilization J:73964
Nos3tm1Weo/Nos3tm1Weo
involves: 129 		normal reproductive system phenotype J:73964
Nos3tm1Weo/Nos3tm1Weo
involves: 129S7/SvEvBrd * C57BL/6 		abnormal cardiac muscle relaxation J:51563
abnormal limb morphology J:51563
postnatal lethality, incomplete penetrance J:51563
short limbs J:51563
syndactyly J:51563
Nos3tm2.1Plh/Nos3tm2.1Plh
involves: 129S4/SvJae * C57BL/6 		decreased adiponectin level J:198075
decreased circulating insulin level J:198075
decreased vasodilation J:198075
increased brown adipose tissue amount J:198075
increased circulating free fatty acids level J:198075
increased circulating LDL cholesterol level J:198075
increased circulating leptin level J:198075
increased inguinal fat pad weight J:198075
increased liver weight J:198075
increased mean systemic arterial blood pressure J:198075
increased retroperitoneal fat pad weight J:198075
increased susceptibility to weight gain J:198075
increased white fat cell size J:198075
insulin resistance J:198075
Nos3tm3.1Plh/Nos3tm3.1Plh
involves: 129S4/SvJae * C57BL/6 		decreased white fat cell size J:198075
improved glucose tolerance J:198075
increased circulating glucose level J:198075
increased circulating insulin level J:198075
Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support. 		last database update
11/12/2024
MGI 6.24 		The Jackson Laboratory